MedTrace Logo

Absorption Comparison on Equivalency Value of Genepro Gen2

NCT02919657 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-24

Study results available
· View outcomes & findings →

Summary

Genepro Gen2 Absorption and Protein Value Clinical Trial.

Conditions

  • Analysis, Event History
  • Absorption; Disorder, Protein

Interventions

DIETARY_SUPPLEMENT

Genepro Protein

weekly blood draws to measure blood protein levels

DIETARY_SUPPLEMENT

Whey Protein

weekly blood draws to measure blood protein levels

Sponsors & Collaborators

  • Musclegen Research, Inc.

    lead OTHER

Principal Investigators

  • David Michael, RN · Musclegen Research, Inc.

  • Brian M Parks, PHD · MedFit Rx, Inc.

  • Tony R Parks, BS · MedFit Rx, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
46 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02919657 on ClinicalTrials.gov